{"id":"https://openalex.org/W2510839866","doi":"https://doi.org/10.1016/j.jacbts.2016.03.012","title":"Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012","display_name":"Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012","publication_year":2016,"publication_date":"2016-08-01","ids":{"openalex":"https://openalex.org/W2510839866","doi":"https://doi.org/10.1016/j.jacbts.2016.03.012","mag":"2510839866","pmid":"https://pubmed.ncbi.nlm.nih.gov/30167520"},"language":"en","primary_location":{"id":"doi:10.1016/j.jacbts.2016.03.012","doi":"https://doi.org/10.1016/j.jacbts.2016.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacbts.2016.03.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2452302X16300237/pdf","source":{"id":"https://openalex.org/S2898156683","display_name":"JACC Basic to Translational Science","issn_l":"2452-302X","issn":["2452-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Basic to Translational Science","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.sciencedirect.com/science/article/pii/S2452302X16300237/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003051203","display_name":"Thomas J. Hwang","orcid":"https://orcid.org/0000-0003-0717-1497","observed_orcids":["https://orcid.org/0000-0003-0717-1497"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas J. Hwang","raw_affiliation_strings":["Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts","Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA","Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Faculty of Arts and Sciences, Harvard University, Cambridge, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061680472","display_name":"Julie C. Lauffenburger","orcid":"https://orcid.org/0000-0002-4940-4140","observed_orcids":["https://orcid.org/0000-0002-4940-4140"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie C. Lauffenburger","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074235726","display_name":"Jessica Myers Franklin","orcid":"https://orcid.org/0000-0002-8941-4116","observed_orcids":["https://orcid.org/0000-0002-8941-4116"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica M. Franklin","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074257304","display_name":"Aaron Seth Kesselheim","orcid":"https://orcid.org/0000-0002-8867-2666","observed_orcids":["https://orcid.org/0000-0002-8867-2666"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aaron S. Kesselheim","raw_affiliation_strings":["Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5074257304"],"corresponding_institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"],"apc_list":{"value":4750,"currency":"USD","value_usd":4750},"apc_paid":{"value":4750,"currency":"USD","value_usd":4750},"fwci":10.3211,"has_fulltext":true,"cited_by_count":38,"citation_normalized_percentile":{"value":0.97832211,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"1","issue":"5","first_page":"301","last_page":"308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.7689999938011169,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.1534000039100647,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12168","display_name":"Health and Medical Research Impacts","score":0.05889999866485596,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiovascular-drug-development","display_name":"cardiovascular drug development","score":0.996999979019165},{"id":"https://openalex.org/keywords/clinical-trial-discontinuation","display_name":"clinical trial discontinuation","score":0.6579999923706055},{"id":"https://openalex.org/keywords/drug-development-timelines","display_name":"drug development timelines","score":0.382999986410141},{"id":"https://openalex.org/keywords/drug-efficacy-and-safety","display_name":"drug safety and efficacy","score":0.5450000166893005},{"id":"https://openalex.org/keywords/translational-research","display_name":"translational research","score":0.6869999766349792},{"id":"https://openalex.org/keywords/pharmaceutical-industry-investment","display_name":"pharmaceutical industry investment","score":0.45500001311302185}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.780386209487915},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.7680063843727112},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.6982972621917725},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.589604914188385},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5489228367805481},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.517410159111023},{"id":"https://openalex.org/C2778738651","wikidata":"https://www.wikidata.org/wiki/Q16546687","display_name":"Novelty","level":2,"score":0.4557996392250061},{"id":"https://openalex.org/C2779174308","wikidata":"https://www.wikidata.org/wiki/Q17092352","display_name":"Patient recruitment","level":3,"score":0.45297685265541077},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.39410486817359924},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38224098086357117},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.26681262254714966},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.10481187701225281},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.0}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.1016/j.jacbts.2016.03.012","doi":"https://doi.org/10.1016/j.jacbts.2016.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacbts.2016.03.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2452302X16300237/pdf","source":{"id":"https://openalex.org/S2898156683","display_name":"JACC Basic to Translational Science","issn_l":"2452-302X","issn":["2452-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Basic to Translational Science","raw_type":"journal-article"},{"id":"pmid:30167520","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30167520","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC. Basic to translational science","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:5065391","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6113354","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6113354","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6113354","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"JACC Basic Transl Sci","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:caf0600b7bfa4fd0a741d6b3703904d1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/caf0600b7bfa4fd0a741d6b3703904d1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JACC: Basic to Translational Science, Vol 1, Iss 5, Pp 301-308 (2016)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.jacbts.2016.03.012","doi":"https://doi.org/10.1016/j.jacbts.2016.03.012","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacbts.2016.03.012","pdf_url":"https://www.sciencedirect.com/science/article/pii/S2452302X16300237/pdf","source":{"id":"https://openalex.org/S2898156683","display_name":"JACC Basic to Translational Science","issn_l":"2452-302X","issn":["2452-302X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-100"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Basic to Translational Science","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/9","display_name":"Industry, innovation and infrastructure","score":0.5799999833106995}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306363","display_name":"Greenwall Foundation","ror":"https://ror.org/00nkfq279"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307776","display_name":"Merck","ror":"https://ror.org/02891sr49"},{"id":"https://openalex.org/F4320308927","display_name":"Patient-Centered Outcomes Research Institute","ror":"https://ror.org/014q65q44"},{"id":"https://openalex.org/F4320311571","display_name":"Laura and John Arnold Foundation","ror":"https://ror.org/04hqxh742"},{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2510839866.pdf","grobid_xml":"https://content.openalex.org/works/W2510839866.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W216869754","https://openalex.org/W1906091442","https://openalex.org/W1964279010","https://openalex.org/W1967836306","https://openalex.org/W1982969737","https://openalex.org/W1983400383","https://openalex.org/W1989730880","https://openalex.org/W1994528036","https://openalex.org/W2001314633","https://openalex.org/W2019178040","https://openalex.org/W2029774593","https://openalex.org/W2031599178","https://openalex.org/W2031638731","https://openalex.org/W2040612932","https://openalex.org/W2048760408","https://openalex.org/W2060333462","https://openalex.org/W2061557450","https://openalex.org/W2064994526","https://openalex.org/W2067539811","https://openalex.org/W2071678348","https://openalex.org/W2078669364","https://openalex.org/W2083258699","https://openalex.org/W2098082628","https://openalex.org/W2108156076","https://openalex.org/W2109314733","https://openalex.org/W2110083155","https://openalex.org/W2113440073","https://openalex.org/W2113698123","https://openalex.org/W2124720149","https://openalex.org/W2124964328","https://openalex.org/W2166209362","https://openalex.org/W2175727876","https://openalex.org/W2196906371","https://openalex.org/W2201508340","https://openalex.org/W2204275981","https://openalex.org/W2211406338","https://openalex.org/W2255675575","https://openalex.org/W2323335855","https://openalex.org/W2580792129","https://openalex.org/W6676550427"],"related_works":["https://openalex.org/W2470067656","https://openalex.org/W2188607138","https://openalex.org/W2041040845","https://openalex.org/W4379330376","https://openalex.org/W2221506788","https://openalex.org/W4200613782","https://openalex.org/W2332746628","https://openalex.org/W1498389988","https://openalex.org/W4367839775","https://openalex.org/W3198386040"],"abstract_inverted_index":{"Cardiovascular":[0],"disease":[1],"remains":[2],"a":[3,102,153],"leading":[4],"cause":[5],"of":[6,17,44,47,62,78,89,106,113,129,142,159,171,206],"death,":[7],"but":[8,197],"stakeholders":[9],"have":[10],"recently":[11],"raised":[12],"concerns":[13],"about":[14],"the":[15,26,37,42,55,76,110,143,169,198,207,229],"pace":[16],"innovation":[18],"and":[19,34,41,60,74,117,121,127,135,165,168,224,227],"investment":[20],"in":[21,31,69,104,145,185,212,222,232],"developing":[22],"new":[23,79,130],"therapeutics.":[24],"Here,":[25],"authors":[27,52],"characterized":[28],"temporal":[29],"trends":[30],"cardiovascular":[32,67,80,116,160,233],"research":[33,223],"development":[35,90,114,225],"over":[36,179],"past":[38],"2":[39],"decades":[40],"likelihood":[43],"successful":[45,107],"completion":[46],"pre-approval":[48],"clinical":[49,83],"trials.":[50],"The":[51,157],"also":[53],"evaluated":[54],"reasons":[56],"for":[57,66,94,101,203],"discontinuation,":[58],"novelty,":[59],"rates":[61],"trial":[63,201],"results":[64,202,216],"publication":[65],"therapies":[68],"late-stage":[70],"development.":[71],"Between":[72],"1990":[73],"2012,":[75],"number":[77,158,170],"drugs":[81,144,173,182,209],"entering":[82,174],"trials":[84,148,161,177],"declined":[85],"across":[86],"all":[87],"stages":[88],"(p":[91],"<":[92],"0.001":[93],"linear":[95],"trends).":[96],"There":[97],"was":[98],"no":[99],"evidence":[100],"difference":[103],"probability":[105],"progression":[108],"to":[109,189],"next":[111],"stage":[112],"between":[115],"noncardiovascular":[118],"drugs.":[119],"Small":[120],"medium-sized":[122,166],"companies":[123,167],"sponsored":[124,162],"43%,":[125],"38%,":[126],"31%":[128],"Phase":[131,133,136,146,175,186,199],"1,":[132],"2,":[134],"3":[137,147,176,187,200],"trials,":[138],"respectively.":[139],"Roughly":[140],"one-half":[141,205],"were":[149,183,210],"categorized":[150],"as":[151],"targeting":[152],"novel":[154,172],"biological":[155],"pathway.":[156],"by":[163],"small":[164],"increased":[178],"time.":[180],"Most":[181],"discontinued":[184,208],"due":[188],"inadequate":[190],"efficacy":[191],"(44%)":[192],"or":[193],"safety":[194],"issues":[195],"(24%),":[196],"only":[204],"published":[211],"peer-reviewed":[213],"journals.":[214],"These":[215],"shed":[217],"light":[218],"on":[219],"important":[220],"shifts":[221],"activity":[226],"confirm":[228],"perceived":[230],"challenges":[231],"translational":[234],"research.":[235]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":2}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}